Family Medicine · Wetumpka, AL
NPI
1629011770
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
73970 Tallassee Highway
Wetumpka, AL, 36092
Phone (334) 567-7850
Groups this clinician bills Medicare through
Medicare paid, 2024
$108K
4,154 services
Medicare patients, 2024
401
Average age 77
Drug cost, 2024
$2.1M
25,182 prescriptions
Company payments, 2025
$1,845
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Spencer J Coleman Sr. was code 99214 (office e&m - established), 631 times for 253 patients. In total Spencer J Coleman Sr. billed 4,154 services in 63 codes, and Medicare paid $108K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 631 | 253 | $70.58 | $45K |
| 96372 Injection Administration | Office | 508 | 150 | $7.46 | $3,787 |
| 36415 Venipuncture Blood Collection | Office | 401 | 246 | $7.61 | $3,052 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 318 | 111 | $4.61 | $1,464 |
| 99308 SNF E&M | Office | 296 | 60 | $45.88 | $14K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 258 | 48 | $0.69 | $178 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 154 | 57 | $0.30 | $45.94 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 118 | 118 | $111.56 | $13K |
| 82947 Clinical Chemistry | Office | 87 | 55 | $3.82 | $332 |
| 71046 X-ray - Chest | Office | 87 | 79 | $17.16 | $1,493 |
| 81003 Clinical Chemistry | Office | 86 | 53 | $2.20 | $189 |
| 83036 Blood Count | Office | 82 | 53 | $9.45 | $775 |
| G0008 Administration of influenza virus vaccine | Office | 79 | 79 | $29.46 | $2,327 |
| 90662 Vaccine Product | Office | 78 | 78 | $81.44 | $6,352 |
| 99310 SNF E&M | Office | 63 | 35 | $96.50 | $6,079 |
By year: 2022 $141K for 4,598 services; 2023 $132K for 5,361 services; 2024 $108K for 4,154 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 401 | 246 | $7.61 | $3,052 |
| 82947 Clinical Chemistry | 87 | 55 | $3.82 | $332 |
| 81003 Clinical Chemistry | 86 | 53 | $2.20 | $189 |
| 83036 Blood Count | 82 | 53 | $9.45 | $775 |
| 87428 Infectious Agent Detection by DNA/RNA | 15 | 15 | $68.88 | $1,033 |
Medicare prescription drug claims, 2024
In 2024, the drug Spencer J Coleman Sr. prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,318 prescriptions and refills. In total Spencer J Coleman Sr. wrote 25,182 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,318 | 2,529 | 230 | $18K |
| Amlodipine Besylate Generic | 935 | 2,016 | 215 | $8,379 |
| Pantoprazole Sodium Generic | 923 | 1,851 | 235 | $16K |
| Atorvastatin Calcium Generic | 867 | 1,662 | 186 | $16K |
| Lisinopril Generic | 673 | 1,772 | 186 | $5,916 |
| Eliquis Apixaban | 584 | 631 | 63 | $267K |
| Gabapentin Generic | 477 | 754 | 116 | $9,114 |
| Potassium Chloride Generic | 459 | 743 | 110 | $9,692 |
| Metformin Hcl Generic | 455 | 1,038 | 110 | $5,476 |
| Trazodone Hcl Generic | 449 | 646 | 93 | $4,786 |
| Furosemide Generic | 447 | 737 | 109 | $2,401 |
| Omeprazole Generic | 409 | 944 | 96 | $6,401 |
| Cefadroxil Generic | 393 | 393 | 281 | $3,308 |
| Losartan Potassium Generic | 380 | 780 | 82 | $5,979 |
| Buspirone Hcl Generic | 378 | 435 | 74 | $4,481 |
Brand drugs: 3,738 claims; generic drugs: 21,351 claims; opioid claims: 821.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Spencer J Coleman Sr. $1,845 ($1,845 in general payments such as food, travel and fees) from 25 companies. The largest payer was Novo Nordisk Inc with $309.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 16 | $309 |
| Neurocrine BioSciences, Inc. NBIX | 8 | $224 |
| Abbvie Inc. ABBV | 13 | $204 |
| Pfizer Inc. PFE | 9 | $180 |
| GlaxoSmithKline, LLC. GSK | 6 | $116 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $99.73 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $93.13 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $83.61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $80.83 |
| Lilly USA, LLC LLY | 5 | $75.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.